
Cervical cancer remains one of the most preventable yet deadly cancers affecting women globally. Despite advancements in medical science, thousands of women—particularly in low- and middle-income countries—continue to die from this disease due to late diagnosis, limited awareness, and inadequate access to preventive healthcare. The challenge we face is not a lack of solutions but the need for stronger implementation of prevention strategies.
Medical practitioners play a pivotal role in shifting the focus from treating advanced cervical cancer to preventing it altogether. With the right strategies, healthcare providers can drive efforts toward eradication by emphasizing vaccination, early detection, and public health education.
Understanding the Shift: Why Prevention is Key
For decades, the medical community has largely dealt with cervical cancer in curative settings, treating women already diagnosed with the disease. While treatment options such as surgery, chemotherapy, and radiation have improved survival rates, the psychological, emotional, and financial toll on patients and their families remains high.
Yet, we know that almost all cases of cervical cancer are caused by the human papillomavirus (HPV)—a virus that can be prevented through vaccination. Additionally, regular screening and early intervention can detect precancerous changes before they progress into full-blown cancer. This means that, instead of focusing primarily on treatment, a proactive approach to prevention could virtually eliminate cervical cancer within a generation.
How Medical Practitioners Can Lead the Fight Against Cervical Cancer
- Promoting HPV Vaccination
The HPV vaccine is the single most effective tool in preventing cervical cancer. Yet, in many countries, vaccination rates remain alarmingly low due to misinformation, cultural stigma, and limited access.
As medical professionals, we have a responsibility to:
Educate parents and young people on the importance of HPV vaccination, dispelling myths and misconceptions.
Advocate for national HPV vaccination programs, ensuring vaccines are accessible and affordable.
Engage schools and community groups to integrate HPV vaccination into routine adolescent healthcare.
In countries where vaccination programs are in place, healthcare providers must actively encourage uptake by making it a routine part of pediatric and adolescent care.
- Expanding Screening and Early Detection Efforts
While vaccination prevents future cases, screening is essential for identifying existing risks. Pap smears and HPV tests can detect precancerous changes, allowing for early treatment before cancer develops.
However, many women—particularly in underserved communities—do not undergo regular screening due to lack of awareness, accessibility, or affordability. Medical practitioners must take the lead in:
Integrating cervical cancer screening into routine healthcare visits for women.
Educating patients on the importance of regular Pap smears and HPV testing.
Advocating for government-backed screening programs that make these tests free or low-cost.
Using mobile clinics and outreach programs to reach rural or marginalized populations.
- Strengthening Public Health Education
One of the biggest barriers to cervical cancer prevention is lack of awareness. Many women do not know that cervical cancer is preventable, nor do they understand the importance of vaccination and screening.
Medical practitioners can:
Leverage media and community engagement to spread accurate information about cervical cancer prevention.
Work with religious and cultural leaders to encourage acceptance of HPV vaccination.
Organize health talks and seminars in schools, workplaces, and community centers.
Train nurses and midwives to educate women during antenatal and postnatal visits.
When healthcare professionals take an active role in community education, we can correct misinformation and encourage more women to seek preventive care.
- Advocating for Policy and Healthcare System Improvements
Beyond individual patient care, medical practitioners must advocate for systemic changes that prioritize cervical cancer prevention. This includes:
Pushing for government policies that mandate HPV vaccination as part of national immunization programs.
Ensuring widespread availability of screening services, particularly in low-resource settings.
Securing funding for research on more accessible and cost-effective cervical cancer prevention methods.
By working with policymakers, non-governmental organizations (NGOs), and international health bodies, healthcare professionals can help shape public health policies that drive long-term change.
A Future Without Cervical Cancer is Possible
The World Health Organization (WHO) has set a global target to eliminate cervical cancer as a public health threat by 2030. This goal is achievable, but only if medical practitioners take an active role in leading prevention efforts.
Instead of waiting to diagnose and treat advanced cervical cancer, the focus must shift to preventing it before it starts. This requires a multi-faceted approach that combines HPV vaccination, regular screening, public education, and policy advocacy.
As healthcare providers, we must ask ourselves: Are we doing enough to prevent cervical cancer, or are we simply treating it? The time to act is now. If we commit to prevention today, we can eradicate cervical cancer for future generations.
Dr. Ayoola Jaiyesimi is a seasoned medical doctor, public health advocate, and healthcare administrator with over 21 years of experience in clinical medicine, public health, and hospital management. She is the Chief Medical Director at Newgate Medical Services Limited, where she oversees institutional healthcare services and public health initiatives. Dr. Jaiyesimi is passionate about preventive medicine and has led numerous campaigns focused on cervical cancer awareness and early detection in Nigeria.